Rosuvastatin 10mg + Aspirin 75mg + Clopidogrel 75mg Capsules – TUVAS GOLD Capsules

TUVAS GOLD Capsules – Triple action to manage clot formation and related cardiovascular risk

TUVAS GOLD Capsules – Rosuvastatin 20 mg+ Aspirin 75 mg+ Clopidogrel 75 mg capsule, combines three medications: Rosuvastatin (a statin), Aspirin (an antiplatelet), and Clopidogrel (a P2Y12 inhibitor). Rosuvastatin reduces cholesterol levels by inhibiting HMG-CoA reductase, which helps in lowering LDL (bad) cholesterol and triglycerides while raising HDL (good) cholesterol. Clopidogrel further enhances this antiplatelet effect by irreversibly inhibiting the P2Y12 receptor on platelets, making them less sticky and preventing clots, while Aspirin prevents the formation of blood clots by inhibiting platelet aggregation through COX-1 enzyme inhibition. This combination is particularly useful in preventing cardiovascular events such as heart attack and stroke in high-risk patients.

Recommended by Specialists

Cardiologists : To treat primary and secondary prevention of cardiovascular events such as heart attacks and strokes.
Neurologists : To reduce the risk of ischemic stroke in high-risk patients.

Key benefits of Rosuvastatin 20 mg+ Aspirin 75 mg+ Clopidogrel 75 mg capsule – TUVAS GOLD Capsules

✅Dual Antiplatelet Therapy (DAPT): The combination of Aspirin and Clopidogrel provides enhanced antiplatelet effects, which are essential for preventing clot formation in patients with coronary artery disease or after stent placement.
✅Triple-Action Cardiovascular Protection: The combination of a statin and two antiplatelet agents offers comprehensive protection by reducing cholesterol levels, preventing blood clot formation, and reducing the risk of cardiovascular events.
✅Statin for Cholesterol Control: Rosuvastatin provides powerful cholesterol-lowering effects, which help reduce the risk of atherosclerosis (plaque buildup in arteries), a key factor in heart attacks and strokes.
✅Convenient : OD-once in a day dose advantage
✅Neurological heath: To reduce the risk of ischemic stroke in high-risk patients.

Indications
✅Secondary prevention of cardiovascular events
✅Post-myocardial infarction therapy
✅After coronary stent placement or angioplasty
✅Prevention of stroke in high-risk patients